These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28915664)

  • 21. Investigation of the cell cycle regulation of cdk3-associated kinase activity and the role of cdk3 in proliferation and transformation.
    Braun K; Hölzl G; Soucek T; Geisen C; Möröy T; Hengstschläger M
    Oncogene; 1998 Oct; 17(17):2259-69. PubMed ID: 9811456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells.
    Sweeney KJ; Sarcevic B; Sutherland RL; Musgrove EA
    Oncogene; 1997 Mar; 14(11):1329-40. PubMed ID: 9178893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
    Marampon F; Ciccarelli C; Zani BM
    Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin 4 regulates G1 cell cycle progression in gastric carcinoma cells.
    Morisaki T; Uchiyama A; Yuzuki D; Essner R; Morton DL; Hoon DS
    Cancer Res; 1994 Feb; 54(4):1113-8. PubMed ID: 8313369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of cyclin expression and cell cycle progression in breast epithelial cells by the helix-loop-helix protein Id1.
    Swarbrick A; Akerfeldt MC; Lee CS; Sergio CM; Caldon CE; Hunter LJ; Sutherland RL; Musgrove EA
    Oncogene; 2005 Jan; 24(3):381-9. PubMed ID: 15489884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the therapeutic and anti-tumor properties of morusin: a review of recent advances.
    Hafeez A; Khan Z; Armaghan M; Khan K; Sönmez Gürer E; Abdull Razis AF; Modu B; Almarhoon ZM; Setzer WN; Sharifi-Rad J
    Front Mol Biosci; 2023; 10():1168298. PubMed ID: 37228582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors.
    Salatino M; Labriola L; Schillaci R; Charreau EH; Elizalde PV
    Exp Cell Res; 2001 Apr; 265(1):152-66. PubMed ID: 11281653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morusin Induces TRAIL Sensitization by Regulating EGFR and DR5 in Human Glioblastoma Cells.
    Park D; Ha IJ; Park SY; Choi M; Lim SL; Kim SH; Lee JH; Ahn KS; Yun M; Lee SG
    J Nat Prod; 2016 Feb; 79(2):317-23. PubMed ID: 26829656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppressive effects of an ethanol extract of Gleditsia sinensis thorns on human SNU-5 gastric cancer cells.
    Lee SJ; Ryu DH; Jang LC; Cho SC; Kim WJ; Moon SK
    Oncol Rep; 2013 Apr; 29(4):1609-16. PubMed ID: 23381601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis.
    Liao DJ; Natarajan G; Deming SL; Jamerson MH; Johnson M; Chepko G; Dickson RB
    Oncogene; 2000 Mar; 19(10):1307-17. PubMed ID: 10713672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
    Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
    J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of cell cycle entry and G1 progression by CSF-1.
    Roussel MF
    Mol Reprod Dev; 1997 Jan; 46(1):11-8. PubMed ID: 8981358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
    Bazarov AV; Adachi S; Li SF; Mateyak MK; Wei S; Sedivy JM
    Cancer Res; 2001 Feb; 61(3):1178-86. PubMed ID: 11221849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc.
    Vlach J; Hennecke S; Alevizopoulos K; Conti D; Amati B
    EMBO J; 1996 Dec; 15(23):6595-604. PubMed ID: 8978686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retinoic acid-mediated G1 arrest is associated with induction of p27(Kip1) and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells.
    Hsu SL; Hsu JW; Liu MC; Chen LY; Chang CD
    Exp Cell Res; 2000 Aug; 258(2):322-31. PubMed ID: 10896783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T-47D breast cancer cells.
    Hui R; Finney GL; Carroll JS; Lee CS; Musgrove EA; Sutherland RL
    Cancer Res; 2002 Dec; 62(23):6916-23. PubMed ID: 12460907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pterocarpanquinone LQB-118 inhibits tumor cell proliferation by downregulation of c-Myc and cyclins D1 and B1 mRNA and upregulation of p21 cell cycle inhibitor expression.
    Martino T; Magalhães FC; Justo GA; Coelho MG; Netto CD; Costa PR; Sabino KC
    Bioorg Med Chem; 2014 Jun; 22(12):3115-22. PubMed ID: 24794748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repression of c-Myc responsive genes in cycling cells causes G1 arrest through reduction of cyclin E/CDK2 kinase activity.
    Berns K; Hijmans EM; Bernards R
    Oncogene; 1997 Sep; 15(11):1347-56. PubMed ID: 9315103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. c-Myc and cyclin D3 (CcnD3) genes are independent targets for glucocorticoid inhibition of lymphoid cell proliferation.
    Rhee K; Bresnahan W; Hirai A; Hirai M; Thompson EA
    Cancer Res; 1995 Sep; 55(18):4188-95. PubMed ID: 7664296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A role for candidate tumor-suppressor gene TCEAL7 in the regulation of c-Myc activity, cyclin D1 levels and cellular transformation.
    Chien J; Narita K; Rattan R; Giri S; Shridhar R; Staub J; Beleford D; Lai J; Roberts LR; Molina J; Kaufmann SH; Prendergast GC; Shridhar V
    Oncogene; 2008 Dec; 27(58):7223-34. PubMed ID: 18806825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.